EKTA.B

51.25

-2.01%↓

EKTA.B

51.25

-2.01%↓

EKTA.B

51.25

-2.01%↓

EKTA.B

51.25

-2.01%↓

EKTA.B

51.25

-2.01%↓

Search

Orexo AB

Closed

14.28 -1.52

Overview

Share price change

24h

Current

Min

14.24

Max

14.32

Key metrics

By Trading Economics

Income

-76M

-98M

Sales

24M

160M

EPS

-3.37

Profit margin

-61.135

Employees

110

EBITDA

34M

33M

Dividends

By Dow Jones

Next Earnings

6 May 2025

Market Stats

By TradingEconomics

Market Cap

501M

Previous open

15.8

Previous close

14.28

Orexo AB Chart

Past performance is not a reliable indicator of future results.

Related News

1 Apr 2025, 23:15 UTC

Major Market Movers

Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update

1 Apr 2025, 23:46 UTC

Market Talk

Market Grapples With Valuing Goodman's Data Centers -- Market Talk

1 Apr 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1 Apr 2025, 23:44 UTC

Market Talk

Global Equities Roundup: Market Talk

1 Apr 2025, 23:44 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

1 Apr 2025, 23:43 UTC

Market Talk

Gold Steady, Underpinned by Signs of Chinese Buying Activity -- Market Talk

1 Apr 2025, 23:11 UTC

Top News

Risk Off Trade Is Getting Crowded. It's More Worry Than Panic. -- Barrons.com

1 Apr 2025, 23:02 UTC

Market Talk

New Zealand May Be Measuring Stick for Trade-War Fallout -- Market Talk

1 Apr 2025, 22:31 UTC

Top News

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1 Apr 2025, 22:26 UTC

Market Talk

RBA's Focus on What It Doesn't Know Boosts May Cut Odds -- Market Talk

1 Apr 2025, 21:47 UTC

Top News

Wilbur Ross Has Thoughts on Trump's Tariffs -- Barrons.com

1 Apr 2025, 21:32 UTC

Top News

Hooters' Bankruptcy Is the Latest Sign of Trouble for Restaurants -- Barrons.com

1 Apr 2025, 21:06 UTC

Market Talk

Mexican Remittances See Slow Start to the Year -- Market Talk

1 Apr 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

1 Apr 2025, 20:50 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Financial Services Roundup: Market Talk

1 Apr 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 Apr 2025, 20:47 UTC

Top News

Boeing Stock Drops. Why Lower 737 MAX Production Report Wasn't Quite Right. -- Barrons.com

1 Apr 2025, 20:47 UTC

Top News

BYD Will Beat Tesla Two Ways This Quarter -- Barrons.com

1 Apr 2025, 20:20 UTC

Top News

Trump's 'Liberation Day' Tariffs Loom; Treasury Yields Fall -- WSJ

1 Apr 2025, 20:15 UTC

Acquisitions, Mergers, Takeovers

Eaton Completes Acquisition Of Fibrebond >ETN

1 Apr 2025, 20:11 UTC

Market Talk

Altria Stock Seen Overvalued Amid Steep Volume Losses -- Market Talk

1 Apr 2025, 20:07 UTC

Acquisitions, Mergers, Takeovers

Johnson & Johnson Intends to Complete Its Acquisition of Intra-Cellular Therapies on or Around April 2 >JNJ

1 Apr 2025, 20:00 UTC

Top News

Americans Are Worried About Tariffs. Consumer Stocks Could Take a Hit. -- Barrons.com

1 Apr 2025, 19:46 UTC

Top News

Visa, American Express Bidding to Win Apple Credit-Card Network, Sources Say -- WSJ

1 Apr 2025, 19:43 UTC

Market Talk

Oil Rally Loses Momentum Ahead of U.S. Tariff Plans -- Market Talk

1 Apr 2025, 19:17 UTC

Top News

Meta's Head of AI Research to Resign Amid Computing Push -- Update

1 Apr 2025, 19:13 UTC

Market Talk

U.S. Natural Gas Futures Give Back Gains -- Market Talk

1 Apr 2025, 19:03 UTC

Market Talk

Don't Rush Into Trade Talks With U.S., Canadian Experts Advise Lawmakers -- Market Talk

1 Apr 2025, 19:00 UTC

Market Talk

Gold Slips Ahead of Tariff Day -- Market Talk

1 Apr 2025, 18:54 UTC

Market Talk

Mexican Manufacturing PMIs Reflect Tariff Threats -- Market Talk

Peer Comparison

Price change

Orexo AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.